DK1368372T3 - Peptid med affinitet til det virale gp120-protein samt anvendelse deraf - Google Patents
Peptid med affinitet til det virale gp120-protein samt anvendelse derafInfo
- Publication number
- DK1368372T3 DK1368372T3 DK02700342T DK02700342T DK1368372T3 DK 1368372 T3 DK1368372 T3 DK 1368372T3 DK 02700342 T DK02700342 T DK 02700342T DK 02700342 T DK02700342 T DK 02700342T DK 1368372 T3 DK1368372 T3 DK 1368372T3
- Authority
- DK
- Denmark
- Prior art keywords
- viral
- protein
- affinity
- peptide
- peptides
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 230000003612 virological effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0100893A FR2819809B1 (fr) | 2001-01-23 | 2001-01-23 | Peptides presentant un affinite pour la proteine virale gp120, et utilisation de ces peptides |
PCT/FR2002/000227 WO2002059146A2 (fr) | 2001-01-23 | 2002-01-21 | Peptides presentant une affinite pour la proteine virale gp120, et utilisation de ces peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1368372T3 true DK1368372T3 (da) | 2008-01-07 |
Family
ID=8859145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02700342T DK1368372T3 (da) | 2001-01-23 | 2002-01-21 | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf |
Country Status (16)
Country | Link |
---|---|
US (1) | US7374875B2 (da) |
EP (1) | EP1368372B1 (da) |
JP (1) | JP4307838B2 (da) |
KR (1) | KR100910199B1 (da) |
CN (1) | CN1304421C (da) |
AT (1) | ATE370160T1 (da) |
AU (1) | AU2002233424B2 (da) |
CA (1) | CA2435097A1 (da) |
DE (1) | DE60221805T2 (da) |
DK (1) | DK1368372T3 (da) |
ES (1) | ES2291439T3 (da) |
FR (1) | FR2819809B1 (da) |
IL (2) | IL156799A0 (da) |
MX (1) | MXPA03006263A (da) |
WO (1) | WO2002059146A2 (da) |
ZA (1) | ZA200305576B (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040076640A1 (en) * | 1999-02-15 | 2004-04-22 | Institut De Recherche Pour Le Developement (I.R.D) | Vaccine compositions against infectious pathologies for mammals |
FR2838649B1 (fr) | 2002-04-19 | 2006-01-13 | Commissariat Energie Atomique | Composition anti-vih, procede de fabrication et medicament |
JP4625433B2 (ja) * | 2005-08-16 | 2011-02-02 | 三洋化成工業株式会社 | タンパク質のリフォールディング剤およびリフォールディング方法 |
WO2007020886A1 (ja) | 2005-08-16 | 2007-02-22 | Sanyo Chemical Industries, Ltd. | タンパク質のリフォールディング剤およびリフォールディング方法 |
WO2007144685A1 (en) * | 2006-06-13 | 2007-12-21 | Commissariat A L'energie Atomique | Cd4 mimic peptides and their uses |
FR2904627B1 (fr) * | 2006-08-04 | 2008-11-07 | Pasteur Institut | Nouveaux peptides actives, purifies et isoles, derives du recepteur cd4 (mini-cd4) et leur procece de preparation |
JP2008209378A (ja) * | 2007-01-31 | 2008-09-11 | Fujifilm Corp | バイオセンサー基板 |
EP2087911A1 (en) * | 2008-02-06 | 2009-08-12 | Institut Pasteur | Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS |
MX371403B (es) * | 2014-03-20 | 2020-01-29 | Bristol Myers Squibb Co | Moleculas de andamiaje a base de fibronectina estabilizada. |
US11174298B2 (en) * | 2016-11-09 | 2021-11-16 | James P. Tam | Preparation and use of ginsentides and ginsentide-like peptides |
CN108640977A (zh) * | 2018-06-18 | 2018-10-12 | 上海大学 | 特异性结合HIV上包膜糖蛋白gp120的多肽及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684622A (en) * | 1984-11-21 | 1987-08-04 | Smithkline Beckman Corporation | Compositions and methods for producing vasodilation and antioxytocic activity |
US4599324A (en) * | 1984-11-21 | 1986-07-08 | Smithkline Beckman Corporation | V1-vasopressin antagonists |
US4721704A (en) * | 1986-05-09 | 1988-01-26 | Peninsula Laboratories, Inc. | Potent synthetic atrial peptide analogs |
-
2001
- 2001-01-23 FR FR0100893A patent/FR2819809B1/fr not_active Expired - Fee Related
-
2002
- 2002-01-21 KR KR1020037009627A patent/KR100910199B1/ko not_active IP Right Cessation
- 2002-01-21 DE DE60221805T patent/DE60221805T2/de not_active Expired - Lifetime
- 2002-01-21 ES ES02700342T patent/ES2291439T3/es not_active Expired - Lifetime
- 2002-01-21 AU AU2002233424A patent/AU2002233424B2/en not_active Ceased
- 2002-01-21 CN CNB028039831A patent/CN1304421C/zh not_active Expired - Fee Related
- 2002-01-21 WO PCT/FR2002/000227 patent/WO2002059146A2/fr active IP Right Grant
- 2002-01-21 CA CA002435097A patent/CA2435097A1/en not_active Abandoned
- 2002-01-21 JP JP2002559448A patent/JP4307838B2/ja not_active Expired - Fee Related
- 2002-01-21 EP EP02700342A patent/EP1368372B1/fr not_active Expired - Lifetime
- 2002-01-21 US US10/466,835 patent/US7374875B2/en not_active Expired - Fee Related
- 2002-01-21 AT AT02700342T patent/ATE370160T1/de not_active IP Right Cessation
- 2002-01-21 IL IL15679902A patent/IL156799A0/xx unknown
- 2002-01-21 DK DK02700342T patent/DK1368372T3/da active
- 2002-01-21 MX MXPA03006263A patent/MXPA03006263A/es active IP Right Grant
-
2003
- 2003-07-06 IL IL156799A patent/IL156799A/en not_active IP Right Cessation
- 2003-07-18 ZA ZA200305576A patent/ZA200305576B/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE60221805D1 (de) | 2007-09-27 |
ES2291439T3 (es) | 2008-03-01 |
JP2004535366A (ja) | 2004-11-25 |
KR20040011454A (ko) | 2004-02-05 |
US20060121538A1 (en) | 2006-06-08 |
AU2002233424B2 (en) | 2006-01-05 |
CN1487951A (zh) | 2004-04-07 |
CA2435097A1 (en) | 2002-08-01 |
FR2819809A1 (fr) | 2002-07-26 |
ZA200305576B (en) | 2004-07-21 |
IL156799A0 (en) | 2004-02-08 |
EP1368372A2 (fr) | 2003-12-10 |
DE60221805T2 (de) | 2008-05-15 |
MXPA03006263A (es) | 2005-04-29 |
WO2002059146A3 (fr) | 2002-12-05 |
KR100910199B1 (ko) | 2009-07-30 |
CN1304421C (zh) | 2007-03-14 |
JP4307838B2 (ja) | 2009-08-05 |
IL156799A (en) | 2010-04-15 |
US7374875B2 (en) | 2008-05-20 |
FR2819809B1 (fr) | 2003-05-16 |
ATE370160T1 (de) | 2007-09-15 |
WO2002059146A2 (fr) | 2002-08-01 |
EP1368372B1 (fr) | 2007-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY28641A1 (es) | Anticuerpos | |
CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
HUP0303246A2 (hu) | Aktív fehérjék fokozott kinyerése | |
WO2002074795A3 (en) | Oligomeric complexes of chimeric proteins with enhanced immunogenic potential | |
HUP0004639A2 (hu) | Chlamydia fehérje, génszekvencia és ezek alkalmazása | |
YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
HUP0402162A2 (hu) | A humán angiopoietin-2 specifikus kötőanyagai | |
AT500379B1 (de) | Tau-proteine | |
DK1368372T3 (da) | Peptid med affinitet til det virale gp120-protein samt anvendelse deraf | |
ATE310748T1 (de) | Entzündungsspezifische peptide und deren verwendungen | |
DK1370284T3 (da) | Bakteriofag-medieret immunisering | |
ATE543906T1 (de) | Antigen von streptococcus aus der b-gruppe | |
DE50002164D1 (de) | Peptide zur inhibierung von hpv e6-proteinen | |
WO2002034915A3 (en) | Preferred segments of neural thread protein and methods of using the same | |
FR2837837B1 (fr) | Epitopes peptidiques communs a des antigenes d'une meme famille multigenique | |
IT1249684B (it) | Epitopi della proteina env del virus dell'epatite c. | |
AUPP627498A0 (en) | Novel peptides - i | |
WO2002042412A3 (en) | Protease inhibitors and their pharmaceutical uses | |
EP1104310A4 (en) | EXPRESSION AND CHARACTERIZATION OF HIV-1 ENVELOPE PROTEIN ASSOCIATED WITH LARGELY REACTIVE NEUTRALIZATION ANTIBODY RESPONSE | |
EA200400392A1 (ru) | Связывающий каспазу-8 белок, его получение и применение | |
DK1183362T3 (da) | IL-1- ETA-DNA og -polypeptider | |
GB0207644D0 (en) | Peptides and their use | |
AU2002229850A1 (en) | Polypeptide inducing hiv-neutralising antibodies | |
WO2000058438A3 (en) | Conformationally constrained peptides | |
ATE328082T1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen |